Insider · CIK 0001299430

Alafi Christopher D

Reports to the SEC for 2 companies · BERKELEY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001299430

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-28	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−38.8K sh	$40.12	−$1.56M	95,000
2021-05-27	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−8,482 sh	$40.01	−$339K	133,843
2021-05-24	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−26.6K sh	$40.47	−$1.08M	142,325
2021-05-21	Intra-Cellular Therapies, Inc.S Sale	Director	SSale	−1,100 sh	$40.00	−$44K	168,900
2021-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+464 sh	$33.93	+$15.7K	346,795
2020-12-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+495 sh	$31.80	+$15.7K	346,331
2020-09-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+613 sh	$25.66	+$15.7K	345,836
2020-09-14	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+49.5K sh	$29.60	+$1.47M	4,743,770
2020-09-11	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+21K sh	$28.08	+$590K	4,694,270
2020-06-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+613 sh	$25.67	+$15.7K	345,223
2020-05-27	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,024 sh	$15.37	+$15.7K	344,610
2019-12-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+422 sh	$34.31	+$14.5K	343,586
2019-09-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,941 sh	$7.47	+$14.5K	343,164
2019-09-10	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+320K sh	$10.58	+$3.39M	4,667,030
2019-09-10	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+3,549 sh	$8.98	+$31.9K	4,191,819
2019-09-10	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+6,240 sh	$11.00	+$68.6K	4,673,270
2019-09-10	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+155K sh	$9.59	+$1.49M	4,346,935
2019-08-30	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+125K sh	$8.52	+$1.07M	4,188,270
2019-06-28	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,117 sh	$12.98	+$14.5K	341,223
2019-06-25	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-06-17	Intra-Cellular Therapies, Inc.G Gift	Director	GGift	−400K sh	—	—	340,106
2019-06-12	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+58.7K sh	$12.00	+$704K	170,000
2019-06-12	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+95.1K sh	$11.70	+$1.11M	111,295
2019-06-12	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+16.2K sh	$10.91	+$177K	16,226
2019-05-14	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+100K sh	$12.56	+$1.26M	4,053,270
2019-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,190 sh	$12.18	+$14.5K	750,106
2018-12-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,273 sh	$11.39	+$14.5K	748,916
2018-09-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+668 sh	$21.70	+$14.5K	747,643
2018-06-29	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+820 sh	$17.67	+$14.5K	746,975
2018-06-18	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-03-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+688 sh	$21.05	+$14.5K	746,155
2017-12-29	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+1,001 sh	$14.48	+$14.5K	745,467
2017-12-29	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,001 sh	$14.48	+$14.5K	745,467
2017-11-22	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+10K sh	$15.55	+$156K	3,963,270
2017-11-22	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+10K sh	$15.55	+$156K	744,466
2017-10-02	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+258K sh	$15.50	+$4M	3,953,270
2017-09-29	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+918 sh	—	—	734,466
2017-06-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+1,167 sh	—	—	733,548
2017-06-27	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+892 sh	—	—	732,381
2016-12-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+960 sh	—	—	731,489
2016-12-07	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+20.8K sh	$16.14	+$336K	3,695,205
2016-12-06	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+44.2K sh	$16.33	+$721K	3,674,379
2016-11-14	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+34K sh	$14.50	+$493K	3,630,205
2016-09-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+951 sh	—	—	730,529
2016-06-30	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+373 sh	—	—	729,578
2016-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-03-31	Intra-Cellular Therapies, Inc.A Award	Director	AAward	+377 sh	—	—	729,205
2016-02-29	Intra-Cellular Therapies, Inc.P Purchase	Director	PPurchase	+100K sh	$29.70	+$2.97M	728,828

Recent filings

Accepted (ET)
May 284
Alafi Christopher D0001209191-21-036624
SEC(opens sec.gov)
May 254
Alafi Christopher D0001209191-21-035750
SEC(opens sec.gov)
Apr 24
Alafi Christopher D0001209191-21-024725
SEC(opens sec.gov)
Jan 54
Alafi Christopher D0001209191-21-001479
SEC(opens sec.gov)
Oct 24
Alafi Christopher D0001209191-20-053110
SEC(opens sec.gov)
Sep 144
Alafi Christopher D0001209191-20-050301
SEC(opens sec.gov)
Sep 114
Alafi Christopher D0001209191-20-050141
SEC(opens sec.gov)
Jul 24
Alafi Christopher D0001209191-20-040673
SEC(opens sec.gov)
May 284
Alafi Christopher D0001209191-20-032741
SEC(opens sec.gov)
Apr 24
Alafi Christopher D0001209191-20-022764
SEC(opens sec.gov)
Jan 34
Alafi Christopher D0001209191-20-001462
SEC(opens sec.gov)
Oct 24
Alafi Christopher D0001209191-19-051848
SEC(opens sec.gov)
Sep 114
Alafi Christopher D0001209191-19-049172
SEC(opens sec.gov)
Sep 44
Alafi Christopher D0001209191-19-048307
SEC(opens sec.gov)
Jul 24
Alafi Christopher D0001209191-19-040359
SEC(opens sec.gov)

Companies

Address

P.O. BOX 7338

BERKELEY, CA, 94707